Vaccine effectiveness relies on creating a strong antibody response that can be reactivated to fight future infections. Now, ...

They divide too quickly and eventually crowd out normal blood cells. This article provides a more in-depth look at leukemia, including how it develops, symptoms, types, treatment, and survival rates.

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

and symptoms. Leukemia is a cancer of the blood or bone marrow. Leukemia develops when damage occurs to the DNA of developing blood cells, mainly white cells. This causes the blood cells to grow ...

Hartmann and his co-workers 1,2 reported the phenomenon of pseudohyperkalemia, an elevation of serum potassium that does not reflect the level of plasma ... cells from similar patients with ...

Feb. 13, 2025 -- The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL). LBCL is a fast-growing cancer of B ...

Chimeric antigen receptor (CAR) T cell therapy is a promising form of adoptive cell therapy. This process re-engineers patient-derived T cells to express a hybrid receptor targeting a selected ...

Neoplastic cell morphology in peripheral blood (A) and bone marrow aspirate films (B) showing small- to medium-sized lymphoplasmacytic lymphocytes (May Grunwald Giemsa stain, 1000×). Bone marrow ...

Components of the bone marrow microenvironment (BMM) have been shown to mediate the way in which leukemia develops, progresses and responds to treatment. Increasing evidence shows that leukemic cells ...

Chimeric antigen receptor (CAR) T-cell therapy exhibits desirable and robust efficacy in patients with acute lymphoblastic leukemia (ALL ... developed B-cell aplasia, plasma cell deficiency, or even ...